Cirrhosis, hyperammonemia and Lactulose
- PMID: 5679042
Cirrhosis, hyperammonemia and Lactulose
Similar articles
-
[Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].Chir Patol Sper. 1975 Apr;23(2):77-95. Chir Patol Sper. 1975. PMID: 1140038 Italian. No abstract available.
-
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.N Engl J Med. 1969 Aug 21;281(8):408-12. doi: 10.1056/NEJM196908212810803. N Engl J Med. 1969. PMID: 4894464 Clinical Trial. No abstract available.
-
[Lactulose in the treatment of chronic portosystemic encephalopathies].Cesk Gastroenterol Vyz. 1974 Apr;28(3):201-7. Cesk Gastroenterol Vyz. 1974. PMID: 4447986 Czech. No abstract available.
-
Hepatic encephalopathy: pathophysiology and advances in therapy.Trop Gastroenterol. 2007 Jan-Mar;28(1):4-10. Trop Gastroenterol. 2007. PMID: 17896602 Review.
-
[Treatment of post-hemorrhagic hepatic encephalopathy in patients with cirrhosis].Gastroenterol Clin Biol. 1990;14(1 ( Pt 2)):29B-33B. Gastroenterol Clin Biol. 1990. PMID: 1968870 Review. French. No abstract available.
Cited by
-
Lactulose.Gut. 1970 Dec;11(12):1043-8. doi: 10.1136/gut.11.12.1043. Gut. 1970. PMID: 4929274 Free PMC article. Review. No abstract available.
-
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921. Am J Dig Dis. 1978. PMID: 354373 Clinical Trial.
-
Some aspects of medical management of gastrointestinal disease. I.Can Med Assoc J. 1975 Jan 25;112(2):200-4, 206. Can Med Assoc J. 1975. PMID: 234288 Free PMC article. Review.
-
Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.Drugs. 1972;4(1):7-48. doi: 10.2165/00003495-197204010-00003. Drugs. 1972. PMID: 4564869 Review. No abstract available.